Nemus Bioscience Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 338M 460M |
---|---|---|---|---|---|
Net income 2024 * | -31M -42.19M | Net income 2025 * | -38M -51.71M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.63
x | P/E ratio 2025 * |
-10.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |